IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CIRELLO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.386
NA - Nord America 4.090
AS - Asia 3.909
Continente sconosciuto - Info sul continente non disponibili 552
SA - Sud America 345
AF - Africa 92
OC - Oceania 17
Totale 13.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.911
GB - Regno Unito 1.356
SG - Singapore 1.121
CN - Cina 1.115
IT - Italia 1.069
DE - Germania 552
BD - Bangladesh 514
HK - Hong Kong 338
SE - Svezia 302
RU - Federazione Russa 287
VN - Vietnam 281
BR - Brasile 253
NL - Olanda 194
IN - India 169
FR - Francia 154
CA - Canada 124
UA - Ucraina 102
TR - Turchia 84
IE - Irlanda 82
FI - Finlandia 80
KR - Corea 78
JP - Giappone 49
CI - Costa d'Avorio 44
EU - Europa 43
ID - Indonesia 43
DK - Danimarca 41
CO - Colombia 35
BE - Belgio 31
AR - Argentina 23
ES - Italia 20
IQ - Iraq 17
MX - Messico 17
PL - Polonia 17
EC - Ecuador 16
UZ - Uzbekistan 14
AT - Austria 13
AU - Australia 13
EG - Egitto 13
GR - Grecia 12
RO - Romania 11
SK - Slovacchia (Repubblica Slovacca) 10
CH - Svizzera 9
JO - Giordania 8
ZA - Sudafrica 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
LV - Lettonia 7
TH - Thailandia 7
TW - Taiwan 7
HR - Croazia 6
IR - Iran 6
KE - Kenya 6
LB - Libano 6
PH - Filippine 6
PK - Pakistan 6
VE - Venezuela 6
MA - Marocco 5
PT - Portogallo 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CL - Cile 3
GT - Guatemala 3
HN - Honduras 3
LT - Lituania 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BH - Bahrain 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
GP - Guadalupe 1
HT - Haiti 1
IL - Israele 1
Totale 12.870
Salva come PNG Salva come JPEG
Città #
Southend 1.225
Singapore 659
Ashburn 493
Milan 349
Chandler 318
Hong Kong 309
San Jose 254
Beijing 212
Dallas 174
Frankfurt am Main 157
Santa Clara 152
Seattle 148
Los Angeles 129
New York 129
Council Bluffs 124
Wilmington 107
Princeton 103
Ho Chi Minh City 95
Ann Arbor 92
Hefei 86
Jacksonville 85
Dublin 81
Bengaluru 74
Hanoi 71
Buffalo 68
Boardman 64
Toronto 63
Fairfield 62
Lauterbourg 59
Dearborn 57
Nanjing 55
Woodbridge 50
Mountain View 48
Guangzhou 47
Rome 47
Shanghai 47
Abidjan 44
Somerville 42
Des Moines 41
Moscow 41
Redmond 39
Houston 38
Tokyo 36
The Dalles 35
Kent 31
Cambridge 30
Columbus 29
Redwood City 29
Serra 29
Bogotá 28
Bühl 28
Sakarya 28
Jakarta 27
Jinan 27
Munich 27
São Paulo 27
Helsinki 26
Naples 26
Chicago 25
Andover 24
Nanchang 24
Cangzhou 23
Phoenix 22
Bologna 21
Hebei 21
Brussels 20
Florence 20
Palermo 20
Shenyang 20
Turin 20
Changsha 19
Da Nang 19
Kiez 19
Seoul 17
Tianjin 17
Atlanta 16
Zhengzhou 15
Ottawa 14
Düsseldorf 13
Nuremberg 13
Verona 13
Berlin 12
Haiphong 12
Fuzhou 11
Istanbul 11
Rio de Janeiro 11
San Diego 11
Athens 10
Besnate 10
Brooklyn 10
Falls Church 10
Hangzhou 10
Mumbai 10
Stockholm 10
Eitensheim 9
Lecco 9
London 9
Miami 9
Orem 9
Bari 8
Totale 7.627
Salva come PNG Salva come JPEG
Nome #
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability 692
Clinical and molecular analyses of thyroid cancer in patients treated for benign diseases 347
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives 324
Segmental Maternal UPD of Chromosome 7q in a Patient With Pendred and Silver Russell Syndromes-Like Features 322
High phenotypic intrafamilial variability in patients with Pendred syndrome and a novel duplication in the SLC26A4 gene: clinical characterization and functional studies of the mutated SLC26A4 protein 294
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature 281
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors 278
Fetal cell microchimerism in papillary thyroid cancer : a possibile role in tumor demage and tissue repair 277
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour : report of three cases with molecular analysis and review of the literature 263
Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report 259
Absence of BRAF mutations in endocrine tumors 253
Telomerase in differentiated thyroid cancer : promoter mutations, expression and localization 252
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases 252
Total iodide organification defect : clinical and molecular characterization of an Italian family 248
Fetal cell microchimerism in papillary thyroid cancer 245
Allelic distribution of six RET polymorphisms in sporadic medullary thyroid cancer and functional analysis of G691S variant 229
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer 229
Fetal cell microchimerism in papillary thyroid cancer : a role in the outcome of the disease 229
Fetal cell microchimerism in papillary thyroid cancer : studies in peripheral blood and tissues 228
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation : clinical and molecular studies 227
Molecular and functional studies of 4 candidate loci in Pendred syndrome and nonsyndromic hearing loss 225
Correlation between B-RAF(V600E) mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature 223
Fetal cell microchimerism in papillary thyroid cancer : a possible role in tumour demage and tissue repair 222
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects 221
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome 221
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers 220
Tumor and normal thyroid spheroids : from tissues to zebrafish 219
Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer. 215
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer 214
Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer 214
Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer? 213
BRAF mutations in an Italian series of thyroid cancers 210
RET genotypes in sporadic medullary thyroid cancer : studies in a large Italian series 210
Gitelman’s sindrome : description of a new case in a family with RTH 208
RET genotypes comprising specific haplotypes of polymorphic variants are associated with sporadic medullary thyroid cancer 203
FAM83B is involved in thyroid cancer cell differentiation and migration 200
Analysis of a deiodinase 2 polymorphism (oRFa-Asp) in patients with Graves’ disease and controls : preliminary results 194
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia : reactive or neoplastic C-cell hyperplasia? 185
The role of Ret genotypes as modifier loci for sporadic medullary cancer 185
Molecular analysis in three cases of medullary and papillary thyroid carcinoma occurring as collision tumors 184
Tissue sensitivity to thyroid hormones may change over time 174
Fetal cell microchimerism and susceptibility to COVID-19 disease in women 173
Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance 167
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies 164
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer 164
Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families 161
Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al 157
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2) : insights from a large series of familial non-medullary thyroid cancers and literature review 153
Fetal microchimerism in women with thyroid cancer 150
Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors 149
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants 149
Fetal cell microchimerism in women with thyroid cancer 147
Fetal microchimerism as an explanation of disease 146
Role of glucocorticoid receptor polymorphism in adrenal incidentalomas 145
Pendred’s sindrome : from genotype to phenotype 143
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer 130
Evidence of a low prevalence of ras mutations in a large medullary thyroid cancer series 124
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies 114
Novel insights into the link between fetal cell microchimerism and maternal cancers 110
Fetal cell microchimerism in human cancers 107
Modifications in the papillary thyroid cancer gene profile over the last 15 years 102
Positive effect of fetal cell microchimerism on tumor presentation and outcome in papillary thyroid cancer 90
Microchimerism and endocrine disorders 88
Cancer 82
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors 60
The therapeutic outcome of intravenous steroid therapy for active Graves{'} orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor 54
Diabetes mellitus in a girl with thyroid hormone resistance syndrome: A little recognized interaction between the two diseases 41
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function 20
Development of a sensitive plasma lenvatinib quantification method and validation in thyroid cancer patients 12
Totale 13.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022588 0 63 17 31 29 26 63 23 99 48 49 140
2022/2023955 119 114 90 111 111 173 13 65 88 10 44 17
2023/2024779 21 50 17 55 199 46 52 39 43 59 83 115
2024/20251.928 86 170 53 185 148 103 93 187 116 223 201 363
2025/20264.595 430 301 419 318 440 224 485 152 354 308 584 580
2026/2027464 347 117 0 0 0 0 0 0 0 0 0 0
Totale 13.391